ERBB2 and invasive breast carcinoma: In conclusion, through the use of CAIA, we have found that Ki67≥14% in invasive breast cancers confers a poorer DFS and OS on multivariate analysis while Ki67≥17% is more strongly associated with ER+HER2-PR<20% (Luminal B) tumours.